Literature DB >> 29268363

Thermal ablation for the treatment of primary and secondary pulmonary malignancies.

Eun Young Kim1, Young Saing Kim2, Jeong Ho Kim1.   

Abstract

Entities:  

Year:  2017        PMID： 29268363      PMCID： PMC5723847          DOI： 10.21037/jtd.2017.09.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up.

Authors:  Jean Palussière; Benjamin Marcet; Edouard Descat; Frédéric Deschamps; Pramod Rao; Alain Ravaud; Véronique Brouste; Thierry de Baère
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-03       Impact factor: 2.740

2.  Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.

Authors:  Hiroshi Kodama; Koichiro Yamakado; Haruyuki Takaki; Masataka Kashima; Junji Uraki; Atsuhiro Nakatsuka; Motoshi Takao; Osamu Taguchi; Tomomi Yamada; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2011-07-06       Impact factor: 2.740

3.  Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer.

Authors:  So Ri Kim; Hyo Jin Han; Seoung Ju Park; Kyung Hoon Min; Min Hee Lee; Chi Ryang Chung; Min Ho Kim; Gong Yong Jin; Yong Chul Lee
Journal:  Eur J Radiol       Date:  2011-02-09       Impact factor: 3.528

Review 4.  Radiofrequency ablation of lung tumors: imaging features of the postablation zone.

Authors:  Fereidoun G Abtin; Jilbert Eradat; Antonio J Gutierrez; Christopher Lee; Michael C Fishbein; Robert D Suh
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

5.  Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.

Authors:  Thierry de Baère; Jean Palussière; Anne Aupérin; Antoine Hakime; Mohamed Abdel-Rehim; Michèle Kind; Clarisse Dromain; Alain Ravaud; Nathalie Tebboune; Valérie Boige; David Malka; Clarisse Lafont; Michel Ducreux
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

6.  Computed tomographic appearance of lung tumors treated with percutaneous cryoablation.

Authors:  Nobutake Ito; Seishi Nakatsuka; Masanori Inoue; Hideki Yashiro; Sota Oguro; Yotaro Izumi; Masafumi Kawamura; Hiroaki Nomori; Sachio Kuribayashi
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

7.  Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

Authors:  T Schneider; A Sevko; C P Heussel; L Umansky; P Beckhove; H Dienemann; S Safi; J Utikal; H Hoffmann; V Umansky
Journal:  Clin Exp Immunol       Date:  2015-04-15       Impact factor: 4.330

8.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

9.  Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.

Authors:  T de Baère; A Aupérin; F Deschamps; P Chevallier; Y Gaubert; V Boige; M Fonck; B Escudier; J Palussiére
Journal:  Ann Oncol       Date:  2015-02-16       Impact factor: 32.976

10.  Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer.

Authors:  Baodong Liu; Lei Liu; Mu Hu; Kun Qian; Yuanbo Li
Journal:  Thorac Cancer       Date:  2014-12-22       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.